Cingulate CING
NASDAQ CING
$5.26 +0.03 (+0.48%)
As of: Sep 22, 2026 · 11:16 AM EDT

Cingulate (CING) Free Cash Flow (2021 - 2025)

Cingulate's (CING) quarterly Free Cash Flow came in at -$3.8 million in Q4 2025, up 12.26% on a YoY basis from -$3.3 million in Q4 2024, and up 11.56% quarter-over-quarter from -$4.2 million in Q3 2025.

Analysis

Cingulate (CING) Free Cash Flow (2021 - 2025) Analysis & Trends

Cingulate (CING) has reported Free Cash Flow for 5 consecutive years, with -$3.8 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 12.26% year-over-year to -$3.8 million; the trailing twelve-month figure through Dec 2025 stood at -$17.4 million (up 6.76% YoY), and the FY2025 full-year result was -$17.4 million, up 6.73% from the prior year.
  • Free Cash Flow climbed to -$3.8 million in Q4 2025 per CING's latest filing, from -$4.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$1.6 million in Q2 2021 and bottomed at -$8.8 million in Q1 2024.
  • Historically, Free Cash Flow has averaged -$3.9 million across 5 years, with a median of -$4.1 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Free Cash Flow tumbled 180.46% in 2022, then surged 59.14% in 2024.
  • Over 5 years, Free Cash Flow stood at -$5.3 million in 2021, then grew by 18.44% to -$4.3 million in 2022, then surged by 36.79% to -$2.7 million in 2023, then plunged by 55.6% to -$4.3 million in 2024, then gained by 12.26% to -$3.8 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$3.8 million, -$4.2 million, and -$4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 7.30 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 3.11 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 6.20 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 302.00 Mn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 3.09 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 3.44 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -389.61 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 437.80 Mn
10 Cingulate 72.81 Mn 72.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.75 Mn
Sep 30, 2025 -4.24 Mn
Jun 30, 2025 -4.80 Mn
Mar 31, 2025 -4.61 Mn
Dec 31, 2024 -4.28 Mn
Sep 30, 2024 -3.68 Mn
Jun 30, 2024 -1.88 Mn
Mar 31, 2024 -8.83 Mn
Dec 31, 2023 -2.75 Mn
Sep 30, 2023 -4.29 Mn
Jun 30, 2023 -4.60 Mn
Mar 31, 2023 -3.61 Mn
Dec 31, 2022 -4.35 Mn
Sep 30, 2022 -3.40 Mn
Jun 30, 2022 -4.41 Mn
Mar 31, 2022 -3.87 Mn
Dec 31, 2021 -5.33 Mn
Sep 30, 2021 -2.60 Mn
Jun 30, 2021 -1.57 Mn
Mar 31, 2021 -1.74 Mn
API Access

Cingulate Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=CING&period=max&api_key=YOUR_API_KEY